10-12 September 2018 //  Lancaster Royal Hotel, London


Christophe Queva

Dr Christophe Queva

CSO, iTeos Therapeutics

Christophe Quéva, Ph.D. joined iTeos therapeutics, a biotech company focused on developing the next wave of immune therapies, after successive positions at AstraZeneca, Amgen, and Gilead Sciences. Christophe led or supported drug discovery programs for Oncology and Inflammatory diseases from target selection to commercial approval for small molecules and biologics. 


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad